Short Decsription
Creative Biolabs offers CHO-Tg(Human CD38) stable cell line which the CD38 gene stably expressed in CHO cells.
Description
CHO-Tg(Human CD38) stable cell line is a cell line derived from Chinese hamster ovary (CHO) cells that has been genetically modified to express the human CD38 gene. CD38 is a cell surface enzyme involved in regulating immune responses and cell signaling. The stable cell line can be used in research studies to investigate the function of CD38 and develop therapies targeting this enzyme. It can also be used in drug screening assays to identify compounds that modulate CD38 activity.
Features
Consistent gene expression;
Reliability and reproducibility;
Applications
Functional assay
Protein Target
CD38
Species
Human
Parental Cell Line
CHO
Background
The CD38 gene encodes a transmembrane glycoprotein that is expressed on the surface of various immune cells, including T and B lymphocytes, natural killer cells, and monocytes. CD38 plays a role in regulating immune responses, cell adhesion, and signaling pathways. CD38 is also known as a surface marker for identifying different cell populations in flow cytometry analysis. Mutations or overexpression of the CD38 gene have been associated with various diseases, including autoimmune disorders, infectious diseases, and cancer. Therapeutic targeting of CD38 has been explored for the treatment of multiple myeloma, a type of cancer that originates in plasma cells. Monoclonal antibodies that target CD38, such as daratumumab, have been approved for the treatment of multiple myeloma and other hematologic malignancies.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.